Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial

Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added above the page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T15:42:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:17:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:14:40.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study record page is currently displaying a 403 error, indicating access is blocked, with the site chrome visible around it.
    Difference
    19%
    Check dated 2026-09-20T22:32:39.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page, signaling a minor update to the page’s template or presentation.
    Difference
    0.0%
    Check dated 2026-08-30T21:53:12.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, signaling a new release of the page template with likely small fixes or improvements rather than substantive content changes.
    Difference
    0.0%
    Check dated 2026-08-09T09:11:20.000Z thumbnail image

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.